speb/financial-data huggingface dataset:
Stock screener scorecard for AXIA3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.701229768744154 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.6861145980948065%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.151802697624698%
Free cash flow margin: 17.662618968238895%
Revenue growth: -23.21807723795021%
Rule of 40 score: -5.555458269711316
Market cap: 120053063680 (Large Cap ($10B-$200B))
P/E ratio: 2.53024541997926
Debt to equity: 0.6467
Free cash flow (dilution adjusted): 426843916.3498099
Operating income: 1037827376.4258555
Net income: 500126996.1977187
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BIM.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11511779 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CARE (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 755770496 (Small Cap ($300M-$2B))
P/E ratio: 5.863793103448276
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CDT (quarterly, report date 2026-03-31)
Altman Z-score: -1.0142894407430556 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.331405107585514%
Capitalized R&D asset: 1783380
ROCI (R&D adjusted): -3.633784861409808%
Rule of 40 score: 0
Market cap: 1931095 (Nano Cap (< $50M))
Debt to equity: 0.008100000000000001
Free cash flow (dilution adjusted): -2092000
Operating income: -3656000
Net income: -4062000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CKX (quarterly, report date 2026-03-31)
Altman Z-score: 19.422351692284927 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.2593455753163997%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3463067446962395%
Free cash flow margin: -30.66389312082503%
Revenue growth: 40.13335085068646%
Rule of 40 score: 9.469457729861432
Market cap: 23528858 (Nano Cap (< $50M))
P/E ratio: 7.1875
Debt to equity: 0
Free cash flow (dilution adjusted): -52331
Operating income: -74839
Net income: 55244
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CLDT (quarterly, report date 2026-03-31)
Altman Z-score: 0.5197429799054524 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.12604745852665447%
Free cash flow margin: 17.487852571699456%
Revenue growth: -0.34544864034958217%
Rule of 40 score: 17.142403931349875
Market cap: 662583552 (Small Cap ($300M-$2B))
P/E ratio: 390.5
Debt to equity: 0.5828
Free cash flow (dilution adjusted): 11805000
Operating income: 1520000
Net income: -4304000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CLM.V (quarterly, report date 2026-03-31)
Altman Z-score: 7.455398377819303 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.955739740328381%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.06213355590489%
Rule of 40 score: 0
Market cap: 38277560 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -595880.5755395684
Operating income: -625785.6115107915
Net income: -619766.9064748202
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CMIG4.SA (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -1.6310968843556626%
Rule of 40 score: -1.6310968843556626
Market cap: 30895366144 (Large Cap ($10B-$200B))
P/E ratio: 1.3474751517577213
Debt to equity: 0.6926000000000001
Operating income: 23202043677.688213
Net income: 186121673.0038023
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for COA.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1451086464 (Small Cap ($300M-$2B))
P/E ratio: 0.2243243243243243
Debt to equity: 1.493
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CRE (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5115522 (Nano Cap (< $50M))
P/E ratio: 7.914285714285715
Debt to equity: 0.5747
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CRE (annual, report date 2025-12-31)
Altman Z-score: 2.113328306884446 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.625720617463038%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.469777573063453%
Free cash flow margin: 8.263058537565504%
Revenue growth: 25.789927224509068%
Rule of 40 score: 34.05298576207457
Market cap: 5115522 (Nano Cap (< $50M))
P/E ratio: 7.914285714285715
Debt to equity: 0.5747
Free cash flow (dilution adjusted): 1390617.4807197943
Operating income: 753851.028277635
Net income: 678323.9074550128
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for EKG.V (annual, report date 2025-12-31)
Altman Z-score: -338.1329596103453 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -168.31546381146242%
Revenue growth: -46.06222260608927%
Rule of 40 score: -214.3776864175517
Market cap: 1975821 (Nano Cap (< $50M))
Debt to equity: -1.0026022024438073
Free cash flow (dilution adjusted): -334367.88321167877
Operating income: -406662.7737226277
Net income: -386487.5912408759
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for EKG.V (quarterly, report date 2025-12-31)
Altman Z-score: -330.86025884087144 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -106.14343611076396%
Revenue growth: 28.939235903518583%
Rule of 40 score: -77.20420020724538
Market cap: 1975821 (Nano Cap (< $50M))
Debt to equity: -1.0026022024438073
Free cash flow (dilution adjusted): -43395.620437956204
Operating income: -109446.71532846715
Net income: -143579.5620437956
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for ENX.PA (quarterly, report date 2026-03-31)
Altman Z-score: 0.030181619878401015 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.214432202985645%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.385935704738889%
Free cash flow margin: 88.45204178537512%
Revenue growth: 11.655426899096579%
Rule of 40 score: 100.1074686844717
Market cap: 14761536512 (Large Cap ($10B-$200B))
P/E ratio: 23.78696148109152
Debt to equity: 0.691
Free cash flow (dilution adjusted): 535287356.32183903
Operating income: 331954022.9885057
Net income: 238850574.71264368
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for EPP.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18811888 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EPP.L (annual, report date 2025-12-31)
Altman Z-score: 2.2788757623007028 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -108.35041467752956%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -56.83613692582453%
Rule of 40 score: 0
Market cap: 18811888 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3294664.864864865
Operating income: -1909871.6216216215
Net income: -2242568.918918919
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for EYE.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 148105296 (Micro Cap ($50M-$300M))
Debt to equity: 0.0066
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for FFU.V (quarterly, report date 2026-03-31)
Altman Z-score: 10.380895048188709 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.050668352445157%
Capitalized R&D asset: 1034.177493042063
ROCI (R&D adjusted): -2.8071988655881173%
Rule of 40 score: 0
Market cap: 10346859 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): 38508.63309352518
Operating income: -186583.45323741008
Net income: -678269.784172662
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FLNC (quarterly, report date 2026-03-31)
Altman Z-score: 1.0935246587121783 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.601802678244077%
Capitalized R&D asset: 40386830
ROCI (R&D adjusted): -4.088511196021993%
Rosenberg metric: 1.2718299983819643
Free cash flow margin: -28.353528031301963%
Revenue growth: -2.1764015200932594%
Rule of 40 score: -30.52992955139522
Market cap: 2477135616 (Mid Cap ($2B-$10B))
Debt to equity: 0.8773000000000001
Free cash flow (dilution adjusted): -131813000
Operating income: -39210000
Net income: -20927000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for H1W.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.5237130206330075 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.2596221133659902%
Capitalized R&D asset: 340480085.34850645
ROCI (R&D adjusted): 4.217084930951193%
Rosenberg metric: 5.370065789473683
Free cash flow margin: -97.72727272727273%
Revenue growth: -9.014919570394131%
Rule of 40 score: -106.74219229766686
Market cap: 5928819200 (Mid Cap ($2B-$10B))
P/E ratio: 893.477821285977
Debt to equity: 0.5372
Free cash flow (dilution adjusted): -1301315789.4736843
Operating income: 247368421.0526316
Net income: 1315789.4736842106
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for HASH.V (quarterly, report date 2025-09-30)
Altman Z-score: 0.7696025345846366 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.07839907668994087%
Free cash flow margin: -2.700013821859271%
Revenue growth: -31.721401385486818%
Rule of 40 score: -34.42141520734609
Market cap: 6930168 (Nano Cap (< $50M))
P/E ratio: 3.3573141486810556
Debt to equity: 0.4921
Free cash flow (dilution adjusted): -175387.7697841727
Operating income: 26679.856115107916
Net income: -213871.22302158276
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ITM.L (quarterly, report date 2025-10-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 704696000 (Small Cap ($300M-$2B))
Debt to equity: 0.0699
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LAC (quarterly, report date 2026-03-31)
Altman Z-score: 0.9582012523205106 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.903228398717808%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3764238008932815%
Rule of 40 score: 0
Market cap: 986485504 (Small Cap ($300M-$2B))
P/E ratio: 104.12211189817415
Debt to equity: 0.46799999999999997
Free cash flow (dilution adjusted): -230009352.51798564
Operating income: -7983453.237410072
Net income: 3329496.402877698
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MCBS (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.597627577093421%
Capitalized R&D asset: 0
Free cash flow margin: 89.26126976634411%
Revenue growth: 22.436005490403836%
Rule of 40 score: 111.69727525674796
Market cap: 1048097728 (Small Cap ($300M-$2B))
P/E ratio: 10.223021582733814
Debt to equity: 0.7931268451482976
Free cash flow (dilution adjusted): 45384000
Net income: 22314000
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MFML.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.265996510122675 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5462820339038745%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5590055473017027%
Revenue growth: 15.957738462907923%
Rule of 40 score: 15.957738462907923
Market cap: 199130160 (Micro Cap ($50M-$300M))
P/E ratio: 3.641467822977959
Debt to equity: 0.7912
Operating income: 77596.43916913947
Net income: 164317.50741839764
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MFML.NS (annual, report date 2026-03-31)
Altman Z-score: 0.8460964823387092 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -37.700089955761484%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.002496514804258%
Free cash flow margin: -22.840685438176667%
Revenue growth: -19.70513265888582%
Rule of 40 score: -42.54581809706249
Market cap: 199130160 (Micro Cap ($50M-$300M))
Debt to equity: 0.7912
Free cash flow (dilution adjusted): -3270262.8232301823
Operating income: 694404.4086477321
Net income: -2532.852903772785
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for PAPL (quarterly, report date 2026-05-31)
Altman Z-score: 0.750297977234301 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 51.965175341069546%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.8454201631884997%
Free cash flow margin: -417.46225078723313%
Revenue growth: -3.9507560889920974%
Rule of 40 score: -421.4130068762252
Market cap: 29061874 (Nano Cap (< $50M))
P/E ratio: 0.36945868148433414
Debt to equity: 0.42710000000000004
Free cash flow (dilution adjusted): -11350329.710144928
Operating income: -320468.115942029
Net income: 18297161.5942029
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for PRE.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 207159904 (Micro Cap ($50M-$300M))
Debt to equity: 0.11630000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RING.OL (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.449675324675324%
Capitalized R&D asset: 0
Free cash flow margin: -71.20253164556962%
Revenue growth: -1.3919636841239134%
Rule of 40 score: -72.59449532969353
Market cap: 6635700736 (Mid Cap ($2B-$10B))
P/E ratio: 0.9700263272747751
Debt to equity: 0.9221221221221222
Free cash flow (dilution adjusted): -23124357.65673176
Net income: 16957862.281603288
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SAFE.L (quarterly, report date 2026-04-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1344407168 (Small Cap ($300M-$2B))
P/E ratio: 0.295945945945946
Debt to equity: 0.49060000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SLI.V (quarterly, report date 2026-03-31)
Altman Z-score: 15.599884795468904 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.7234773374042762%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.3695952461622667%
Rule of 40 score: 0
Market cap: 736454400 (Small Cap ($300M-$2B))
Debt to equity: 0.0005847920953762807
Free cash flow (dilution adjusted): -5001438.848920863
Operating income: -3780575.5395683455
Net income: -1969784.1726618707
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for SXTC (annual, report date 2026-03-31)
Altman Z-score: 1.0222633974149855 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -20.409571445415445%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -23.42665185431439%
Free cash flow margin: -929.1417263886009%
Revenue growth: -31.317656042554404%
Rule of 40 score: -960.4593824311553
Market cap: 2438313 (Nano Cap (< $50M))
Debt to equity: 0.0377
Free cash flow (dilution adjusted): -1530262.8075253256
Operating income: -1030815.1953690303
Net income: -897986.2518089724
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for SXTC (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2438313 (Nano Cap (< $50M))
Debt to equity: 0.0377
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TGH.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14817581 (Nano Cap (< $50M))
Debt to equity: 0.1013
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TNMG (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1090428 (Nano Cap (< $50M))
Debt to equity: 0.5806
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TNMG (annual, report date 2025-12-31)
Altman Z-score: -2.623025390901823 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 40765.35509049882
ROCI (R&D adjusted): -47.559046451914284%
Rosenberg metric: -1.214625586339982
Free cash flow margin: -12.845612572208658%
Revenue growth: -6.818139602708009%
Rule of 40 score: -19.663752174916667
Market cap: 1090428 (Nano Cap (< $50M))
Debt to equity: 0.5806
Free cash flow (dilution adjusted): -36974.41340067771
Operating income: -63692.09129851033
Net income: -284833.5656287961
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for WIT (annual, report date 2026-03-31)
Altman Z-score: 4.642013184595118 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 31.339418464012898%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.677322520004331%
Free cash flow margin: 13.954050785973399%
Revenue growth: -5.749494813786585%
Rule of 40 score: 8.204555972186814
Market cap: 24025864192 (Large Cap ($10B-$200B))
P/E ratio: 16.307692307692307
Debt to equity: 0.2285
Free cash flow (dilution adjusted): 1369732937.68546
Operating income: 1580394234.8452735
Net income: 1405839338.70284
Long score: 8 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for WIT (quarterly, report date 2026-06-30)
Altman Z-score: 3.1457677278984293 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.040898357031605%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.230045242891581%
Free cash flow margin: 11.806230748490517%
Revenue growth: 0.5415705454015506%
Rule of 40 score: 12.347801293892067
Market cap: 18498476032 (Large Cap ($10B-$200B))
P/E ratio: 17.307692307692307
Debt to equity: 0.27399999999999997
Free cash flow (dilution adjusted): 304884481.48538876
Operating income: 405390864.01519144
Net income: 354077434.32851565
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZJK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 115780040 (Micro Cap ($50M-$300M))
P/E ratio: 12.5
Debt to equity: 0.08839999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZWM.SW (quarterly, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10108800 (Nano Cap (< $50M))
Debt to equity: 0.3368
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 323A.T (annual, report date 2026-02-28)
Altman Z-score: 0.9081206094939965 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.4339390277018165%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.135819958706872%
Free cash flow margin: 2.4183700681672504%
Revenue growth: 8.443571664718078%
Rule of 40 score: 10.86194173288533
Market cap: 1460083800.0000002 (Small Cap ($300M-$2B))
P/E ratio: 109.73948139797068
Debt to equity: 1.7649647170026563
Free cash flow (dilution adjusted): 165821.8914410368
Operating income: 195739.76645707685
Net income: 85365.07121775953
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 7693.T (annual, report date 2025-03-31)
Altman Z-score: 5.032087629131258 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.213109026057465%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.396375748305336%
Free cash flow margin: 1.5451995602479442%
Revenue growth: -4.75499223690717%
Rule of 40 score: -3.2097926766592257
Market cap: 501600000 (Small Cap ($300M-$2B))
P/E ratio: 6.227342702487957
Debt to equity: 0.005849227783766324
Free cash flow (dilution adjusted): 469790.13500868867
Operating income: 343209.46397540433
Net income: 538350.4879026868
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 7805.T (annual, report date 2025-08-31)
Altman Z-score: 2.7561365815628722 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.26263040885911%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.281257047318325%
Free cash flow margin: 11.057712657712658%
Revenue growth: -2.2791210478968797%
Rule of 40 score: 8.778591609815779
Market cap: 3370166462.0000005 (Mid Cap ($2B-$10B))
P/E ratio: 7.782593396899586
Debt to equity: 0.27294753584883674
Free cash flow (dilution adjusted): 6940731.657469856
Operating income: 3837298.1810750053
Net income: 2950057.9058518973
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 8412.HK (annual, report date 2025-05-31)
Altman Z-score: -3.8597765402990247 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -96.80272108843538%
Free cash flow margin: -13.368350584479117%
Revenue growth: -56.592611945332784%
Rule of 40 score: -69.9609625298119
Market cap: 50121516 (Micro Cap ($50M-$300M))
Debt to equity: 0.6625850340136055
Free cash flow (dilution adjusted): -662244.8979591837
Operating income: -726020.4081632653
Net income: -487500
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for AISP (annual, report date 2025-12-31)
Altman Z-score: -0.7193835641863238 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -415.40277121567766%
Capitalized R&D asset: 5856477.340000001
ROCI (R&D adjusted): -36.80105608134496%
Rosenberg metric: -1.0085903424514437
Free cash flow margin: -62.88490654445636%
Revenue growth: -33.530553492065344%
Rule of 40 score: -96.41546003652171
Market cap: 99530334.18 (Micro Cap ($50M-$300M))
P/E ratio: 3.3944647859651003
Debt to equity: -0.12080940556184491
Free cash flow (dilution adjusted): -9634816
Operating income: -7215786
Net income: 29321363
Long score: 2 | Short score: 16
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ASP.AX (quarterly, report date 2024-09-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 17635029 (Nano Cap (< $50M))
Debt to equity: 0.08720159151193631
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ATHM (annual, report date 2025-12-31)
Altman Z-score: 4.479336841389463 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.114683789986884%
Capitalized R&D asset: 335558804.4943728
ROCI (R&D adjusted): 2.2655088318108123%
Rosenberg metric: -0.5219052538269975
Free cash flow margin: 8.562126958492133%
Revenue growth: -4.41846131841866%
Rule of 40 score: 4.143665640073473
Market cap: 17325160141.73 (Large Cap ($10B-$200B))
P/E ratio: 11.001540608949488
Debt to equity: 0.0017347063684818444
Free cash flow (dilution adjusted): 78918714.28571428
Operating income: 109898142.85714285
Net income: 224970571.42857143
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AXIA3.SA (annual, report date 2025-12-31)
Altman Z-score: 0.7848337991555582 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.698780646032937%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.343725221489673%
Free cash flow margin: 25.07360408795761%
Revenue growth: 13.904855783192252%
Rule of 40 score: 38.97845987114986
Market cap: 98404699444.8754 (Large Cap ($10B-$200B))
P/E ratio: 15.001500756041882
Debt to equity: 0.6520101402463933
Free cash flow (dilution adjusted): 2189983029.19708
Operating income: 2425224270.0729923
Net income: 1197017700.7299268
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AXON (annual, report date 2025-12-31)
Altman Z-score: 8.24889546820916 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.270911854810841%
Capitalized R&D asset: 1080402580
ROCI (R&D adjusted): 2.203925399711987%
Rosenberg metric: 0.9437309921126467
Free cash flow margin: -20.11666695448449%
Revenue growth: 33.469450081295506%
Rule of 40 score: 13.352783126811016
Market cap: 45776337590.60999 (Large Cap ($10B-$200B))
P/E ratio: 367.22129372521175
Debt to equity: 0.5889193371610574
Free cash flow (dilution adjusted): -559150000
Operating income: -62076000
Net income: 124656000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CARE (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.463766033470318%
Capitalized R&D asset: 0
Free cash flow margin: 19.952761822964195%
Revenue growth: 12.5602332291053%
Rule of 40 score: 32.5129950520695
Market cap: 435329175.9 (Small Cap ($300M-$2B))
P/E ratio: 13.880784895733692
Debt to equity: 0.4253068284977019
Free cash flow (dilution adjusted): 29736000
Net income: 31362000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CDT (annual, report date 2025-12-31)
Altman Z-score: -30.683515447378955 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 7346960
ROCI (R&D adjusted): -19465.79264617239%
Rule of 40 score: 0
Market cap: 201944640 (Micro Cap ($50M-$300M))
Debt to equity: -0.10808926080892609
Free cash flow (dilution adjusted): -20141000
Operating income: -36660000
Net income: -39224000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CKX (annual, report date 2025-12-31)
Altman Z-score: 15.566722568417141 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.969522618637498%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.3864235012293459%
Free cash flow margin: 54.812931477574786%
Revenue growth: -44.87346199257917%
Rule of 40 score: 9.939469484995612
Market cap: 18786130.35 (Nano Cap (< $50M))
P/E ratio: 6.2412973775171325
Debt to equity: 0
Free cash flow (dilution adjusted): 459630
Operating income: 83295
Net income: 3009972
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CLDT (annual, report date 2025-12-31)
Altman Z-score: 0.44691048234965364 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.11768326759377%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.331251005911019%
Free cash flow margin: 19.5584173515208%
Revenue growth: -6.977733923060191%
Rule of 40 score: 12.580683428460608
Market cap: 311363737.4 (Small Cap ($300M-$2B))
P/E ratio: 20.33329441650885
Debt to equity: 0.46138482280678983
Free cash flow (dilution adjusted): 57712000
Operating income: 26507000
Net income: 15313000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CLM.V (annual, report date 2025-12-31)
Altman Z-score: 55.66192555630704 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -48.93833802847659%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -49.056399043501045%
Rule of 40 score: 0
Market cap: 27341113.25 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -846848.1751824816
Operating income: -1049408.7591240874
Net income: -1046883.2116788321
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for CMIG4.SA (annual, report date 2025-12-31)
Altman Z-score: 1.3986544322728303 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 58.091534549805566%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.038199596697483%
Free cash flow margin: 5.752373645343819%
Revenue growth: 18.71697181619544%
Rule of 40 score: 24.46934546153926
Market cap: 19800928960.87153 (Large Cap ($10B-$200B))
P/E ratio: 4.04183077380517
Debt to equity: 0.6956719498967845
Free cash flow (dilution adjusted): 547262773.7226276
Operating income: 1154744525.547445
Net income: 893978102.189781
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ENX.PA (annual, report date 2025-12-31)
Altman Z-score: 0.050602020321718594 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -38.647949670794226%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.102080696431576%
Free cash flow margin: 36.377567212721615%
Revenue growth: 26.3340812701013%
Rule of 40 score: 62.711648482822916
Market cap: 12495440855.52 (Large Cap ($10B-$200B))
P/E ratio: 18.106500512267644
Debt to equity: 0.7183204130328551
Free cash flow (dilution adjusted): 778082352.9411765
Operating income: 1087344705.882353
Net income: 811891764.7058824
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for EYE.L (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 610556.5342 (Nano Cap (< $50M))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for FFU.V (annual, report date 2025-09-30)
Altman Z-score: 8.741073438416143 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.022988551920072%
Capitalized R&D asset: 771.9424460431655
ROCI (R&D adjusted): -10.493740877684948%
Rule of 40 score: 0
Market cap: 8277487.400000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1925958.9928057555
Operating income: -752337.4100719425
Net income: -888907.1942446043
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for FLNC (annual, report date 2025-09-30)
Altman Z-score: 1.6057559673281905 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.027902182412738%
Capitalized R&D asset: 152448960
ROCI (R&D adjusted): -2.8993867413252823%
Rosenberg metric: -0.6842661832464688
Free cash flow margin: -8.612091937971478%
Revenue growth: -16.146821899960052%
Rule of 40 score: -24.75891383793153
Market cap: 1434364092 (Small Cap ($300M-$2B))
Debt to equity: 0.7120441360813923
Free cash flow (dilution adjusted): -194877000
Operating income: -46337000
Net income: -48314000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for H1W.DE (annual, report date 2025-12-31)
Altman Z-score: 0.8203751762770648 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.493398193189714%
Capitalized R&D asset: 1191100427.6428328
ROCI (R&D adjusted): 9.890221630193393%
Rosenberg metric: 0.7694180667153642
Free cash flow margin: -34.72934472934473%
Revenue growth: 34.99091407309123%
Rule of 40 score: 0.2615693437465012
Market cap: 8295365043.444707 (Mid Cap ($2B-$10B))
Debt to equity: 0.5312965722801789
Free cash flow (dilution adjusted): -1647297297.2972972
Operating income: 593243243.2432432
Net income: -368918918.9189189
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for HASH.V (annual, report date 2024-12-31)
Altman Z-score: 2.2682747584057577 (Grey Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -142.45872859096534%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -24.11350934214417%
Free cash flow margin: -33.09714353511166%
Revenue growth: 171.33702876004236%
Rule of 40 score: 138.2398852249307
Market cap: 90092183.22 (Micro Cap ($50M-$300M))
Debt to equity: 0.6491610067156078
Free cash flow (dilution adjusted): -4744279.720279721
Operating income: -2856380.4195804195
Net income: -3632649.6503496505
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for INTT (annual, report date 2025-12-31)
Altman Z-score: 2.6042655573640126 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 17681100
ROCI (R&D adjusted): -1.4787951384641098%
Rosenberg metric: -0.7608797379503978
Free cash flow margin: 3.5783000219635404%
Revenue growth: -12.904583365215395%
Rule of 40 score: -9.326283343251854
Market cap: 93857987.78999999 (Micro Cap ($50M-$300M))
Debt to equity: 0.16374743058973393
Free cash flow (dilution adjusted): 4073000
Operating income: -2875000
Net income: -2527000
Long score: 5 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for ITM.L (annual, report date 2025-04-30)
Altman Z-score: -1.0654142593245453 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.977970206069966%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -16.61983348499%
Free cash flow margin: -130.2726574500768%
Revenue growth: 68.24762250893453%
Rule of 40 score: -62.025034941142266
Market cap: 2139625.4343000003 (Nano Cap (< $50M))
Debt to equity: 0.05498651089161893
Free cash flow (dilution adjusted): -45230666.666666664
Operating income: -55281333.333333336
Net income: -60686666.666666664
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for LAC (annual, report date 2025-12-31)
Altman Z-score: 1.4220600520205309 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -80.30760686618422%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.1996653940985644%
Rule of 40 score: 0
Market cap: 2096966393.5896003 (Mid Cap ($2B-$10B))
Debt to equity: 0.335425163347407
Free cash flow (dilution adjusted): -607643795.620438
Operating income: -38570072.992700726
Net income: -62964963.50364963
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MT.AS (annual, report date 2025-12-31)
Altman Z-score: 1.9204693123913035 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.973985262386516%
Earnings yield: 3.097246016428324%
Return on net tangible assets: 3.9643190961921397%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9432584493835041%
Free cash flow margin: 0.7677011344373452%
Revenue growth: 10.971429971069169%
Rule of 40 score: 11.739131105506514
Market cap: 29406684651.109997 (Large Cap ($10B-$200B))
P/E ratio: 9.067741181347516
Debt to equity: 0.2371940002830055
Free cash flow (dilution adjusted): 554117647.0588236
Operating income: 1718823529.4117649
Net income: 3815294117.647059
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SCZ.V (annual, report date 2025-12-31)
Altman Z-score: 4.359875881609587 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 36.97100505694639%
Earnings yield: 7.517331702316603%
Return on net tangible assets: 38.808743703848606%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.731039406152643%
Free cash flow margin: 14.231483353861426%
Revenue growth: 20.385778212349322%
Rule of 40 score: 34.61726156621075
Market cap: 1226959447.77 (Small Cap ($300M-$2B))
P/E ratio: 29.059718814125336
Debt to equity: 0.29033050743334554
Free cash flow (dilution adjusted): 33904379.56204379
Operating income: 60515328.46715328
Net income: 30818978.10218978
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ZTS (annual, report date 2025-12-31)
Altman Z-score: 5.560681295376061 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 42.30769230769231%
Earnings yield: 9.24634979013993%
Return on net tangible assets: -585.0230414746544%
Capitalized R&D asset: 1360240000
ROCI (R&D adjusted): 24.869382630768133%
Rosenberg metric: 0.3848396501457726
Free cash flow margin: 23.238618358508504%
Revenue growth: 2.2796024200518583%
Rule of 40 score: 25.518220778560362
Market cap: 52294515439.32 (Large Cap ($10B-$200B))
P/E ratio: 19.56397884
Debt to equity: 2.773341338937256
Free cash flow (dilution adjusted): 2200000000
Operating income: 3597000000
Net income: 2673000000
Long score: 9 | Short score: 4
Recommendation: Long
Stock screener scorecard for 0251.HK (annual, report date 2025-12-31)
Altman Z-score: 0.962519309848165 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 38.17575875677758%
Earnings yield: 1.3850069451837508%
Return on net tangible assets: -3.9530264746277197%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.630455562677823%
Free cash flow margin: 28.968460374503497%
Revenue growth: 1.8686461939352423%
Rule of 40 score: 30.837106568438738
Market cap: 758674688 (Small Cap ($300M-$2B))
Debt to equity: 1.7068
Free cash flow (dilution adjusted): 31497429.305912595
Operating income: 78815424.16452442
Net income: -23996786.632390745
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0383.HK (annual, report date 2025-12-31)
Altman Z-score: 1.6111064632461074 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 2.806667510798441%
Earnings yield: 0.6061159382761322%
Return on net tangible assets: -6.923708493951581%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2402260481409466%
Free cash flow margin: -4.221697249386515%
Revenue growth: 0.4160364134870386%
Rule of 40 score: -3.8056608358994763
Market cap: 858950912 (Small Cap ($300M-$2B))
Debt to equity: 0.4802
Free cash flow (dilution adjusted): -8889331.619537275
Operating income: 6809383.033419023
Net income: -2674293.059125964
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 0468.HK (annual, report date 2025-12-31)
Altman Z-score: 4.809358326620741 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.579608958912221%
Earnings yield: 0.2529001926186476%
Return on net tangible assets: 3.770926083292805%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.944456401770756%
Free cash flow margin: 8.57036077283385%
Revenue growth: -13.544765819839755%
Rule of 40 score: -4.974405047005906
Market cap: 3517822464 (Mid Cap ($2B-$10B))
P/E ratio: 5.861182519280204
Debt to equity: 0.0046
Free cash flow (dilution adjusted): 22735428.57142857
Operating income: 8066285.714285715
Net income: 7562714.285714285
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1645.HK (annual, report date 2025-12-31)
Altman Z-score: 1.701778679722716 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 9.059659969088099%
Earnings yield: 0.11516724420275849%
Return on net tangible assets: -27.17795739164378%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.0375565066432895%
Free cash flow margin: -11.232326278447587%
Revenue growth: 38.45376737276525%
Rule of 40 score: 27.22144109431766
Market cap: 1500176256 (Small Cap ($300M-$2B))
P/E ratio: 10.05784061696658
Debt to equity: 1.2405
Free cash flow (dilution adjusted): -7875000
Operating income: 2093428.5714285714
Net income: 3109714.285714286
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 1685.HK (annual, report date 2025-12-31)
Altman Z-score: 0.9601479981351736 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 19.78557504873294%
Earnings yield: 0.4976927699764182%
Return on net tangible assets: 10.63174009646128%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.064863102998695%
Free cash flow margin: 17.408206809879793%
Revenue growth: -0.7072381545977671%
Rule of 40 score: 16.700968655282026
Market cap: 657703680 (Small Cap ($300M-$2B))
P/E ratio: 1.113967437874893
Debt to equity: 0.748
Free cash flow (dilution adjusted): 16107714.285714285
Operating income: 3973000
Net income: 2653000
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1966.T (annual, report date 2026-03-31)
Altman Z-score: 2.321911498939927 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 7.113546800383437%
Earnings yield: 0.055146632121432664%
Return on net tangible assets: 3.1336413379658943%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.243499389123322%
Free cash flow margin: -4.916654016180591%
Revenue growth: -13.444601900590158%
Rule of 40 score: -18.361255916770748
Market cap: 12791947264 (Large Cap ($10B-$200B))
P/E ratio: 0.064779073125539
Debt to equity: 0.5596
Free cash flow (dilution adjusted): -16516066.066066066
Operating income: 11129817.317317316
Net income: 7850031.281281281
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 2245.HK (annual, report date 2025-12-31)
Altman Z-score: 1.9762152186405435 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 20.35701775153583%
Earnings yield: 1.9726557121139072%
Return on net tangible assets: 11.349597039201015%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.317550664007605%
Free cash flow margin: 4.156063354810088%
Revenue growth: 43.551495052751285%
Rule of 40 score: 47.70755840756137
Market cap: 22529886208 (Large Cap ($10B-$200B))
P/E ratio: 1.2986229286602218
Debt to equity: 0.8898999999999999
Free cash flow (dilution adjusted): 238913000
Operating income: 827789714.2857143
Net income: 677923428.5714285
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 2871.T (annual, report date 2026-03-31)
Altman Z-score: 3.518263438830483 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 12.030214331759284%
Earnings yield: 0.03875986594013905%
Return on net tangible assets: 7.998169617907738%
Capitalized R&D asset: 26508337.754765976
ROCI (R&D adjusted): 9.423486933678623%
Rosenberg metric: -2.3886009195959357
Free cash flow margin: 2.320762304787864%
Revenue growth: -4.518785250610679%
Rule of 40 score: -2.198022945822815
Market cap: 538827227136 (Mega Cap (>= $200B))
P/E ratio: 0.11303271898630121
Debt to equity: 0.40979999999999994
Free cash flow (dilution adjusted): 103978978.97897898
Operating income: 244019019.019019
Net income: 180411661.66166165
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 4022.T (annual, report date 2026-03-31)
Altman Z-score: 4.706834172460202 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 17.89636596327271%
Earnings yield: 0.04929468117248608%
Return on net tangible assets: 5.558176842502595%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.509014469577775%
Free cash flow margin: 3.721164120937834%
Revenue growth: -1.64156169775817%
Rule of 40 score: 2.079602423179664
Market cap: 73630629888 (Large Cap ($10B-$200B))
P/E ratio: 0.09222637818390125
Debt to equity: 0.23579999999999998
Free cash flow (dilution adjusted): 11111111.11111111
Operating income: 37618868.868868865
Net income: 27271021.02102102
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 5976.T (annual, report date 2026-03-31)
Altman Z-score: 2.965329187073349 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.154421689356951%
Earnings yield: 0.025616851259295022%
Return on net tangible assets: 0.26662343043470416%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5211091281996643%
Free cash flow margin: -3.874598898364706%
Revenue growth: -5.232822376430249%
Rule of 40 score: -9.107421274794955
Market cap: 44038340608 (Large Cap ($10B-$200B))
P/E ratio: 0.19753287727143937
Debt to equity: 0.18350000000000002
Free cash flow (dilution adjusted): -14126626.626626626
Operating income: 11843093.093093093
Net income: 11079829.829829829
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7241.T (annual, report date 2026-03-31)
Altman Z-score: 2.861584864383359 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 12.144947662835746%
Earnings yield: 0.09109192412136462%
Return on net tangible assets: 11.8194815873886%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.544427614836575%
Free cash flow margin: 1.5321889488272198%
Revenue growth: -10.257390927861616%
Rule of 40 score: -8.725201979034397
Market cap: 89303040000 (Large Cap ($10B-$200B))
P/E ratio: 0.03342718066644446
Debt to equity: 0.3679
Free cash flow (dilution adjusted): 64983733.733733736
Operating income: 117085835.83583583
Net income: 107651401.4014014
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 8279.HK (annual, report date 2026-03-31)
Altman Z-score: 0.5572786009974057 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.623959800478504%
Earnings yield: 0.3704380592234361%
Return on net tangible assets: -1.1424007581012858%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1696590907121323%
Free cash flow margin: 712.3101137246703%
Revenue growth: 22.721944267748853%
Rule of 40 score: 735.0320579924191
Market cap: 8173530112 (Mid Cap ($2B-$10B))
Debt to equity: 0.0233
Free cash flow (dilution adjusted): 690978061.2244898
Operating income: 7983418.367346939
Net income: -6911096.9387755105
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 9658.T (annual, report date 2026-03-31)
Altman Z-score: 3.3187670193715824 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 20.674334746541444%
Earnings yield: 0.07982890342957204%
Return on net tangible assets: 10.942211852868072%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.217601857796042%
Revenue growth: 1.5567856157417492%
Rule of 40 score: 1.5567856157417492
Market cap: 33494493184 (Large Cap ($10B-$200B))
P/E ratio: 0.06334416980804813
Debt to equity: 0.1057
Operating income: 20410085.085085083
Net income: 18955918.41841842
Long score: 8 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 9828.T (annual, report date 2026-03-31)
Altman Z-score: 2.933538252206634 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 24.626674193051777%
Earnings yield: 0.04868646191795858%
Return on net tangible assets: 15.672949296522429%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.77268279043758%
Free cash flow margin: 2.4636757064752888%
Revenue growth: 2.2616742824755%
Rule of 40 score: 4.725349988950789
Market cap: 59512602624 (Large Cap ($10B-$200B))
P/E ratio: 0.09098801561646573
Debt to equity: 1.5781
Free cash flow (dilution adjusted): 11361361.361361362
Operating income: 30023773.773773775
Net income: 21846846.846846845
Long score: 6 | Short score: 2
Recommendation: Neutral